HHS Finalizes Historic Rules to Provide Patients More Control of Their Health Data
Final rules require access to health information, spur innovation, and aim to end information blocking.
Read MorePosted by | Mar 11, 2020 | Compliance, Information Technology |
Final rules require access to health information, spur innovation, and aim to end information blocking.
Read MorePosted by | Mar 9, 2020 | Compliance, Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases |
FDA and the Federal Trade Commission (FTC) issued warning letters to seven companies for selling fraudulent COVID-19 products.
Read MorePosted by Steve Halasey | Mar 8, 2020 | Compliance |
FDA has recently issued two guidance documents for developers of in vitro diagnostics.
Read MorePosted by Steve Halasey | Mar 5, 2020 | Covid 19, Emerging & Zoonotic Diseases, Infectious Diseases |
CMS calls on all healthcare providers to activate infection control practices and issues guidance to inspectors as they inspect facilities affected by coronavirus.
Read MorePosted by | Feb 29, 2020 | Diagnostic Technologies, Mass Spectrometry |
The systems are equipped with a spectral evaluation function that helps to improve the efficiency of quality control operations by eliminating the need for manual data analysis after spectra are acquired.
Read More